De Giorgi, Ugo Federico Francesco
 Distribuzione geografica
Continente #
NA - Nord America 184
EU - Europa 144
AS - Asia 89
AF - Africa 7
SA - Sud America 1
Totale 425
Nazione #
US - Stati Uniti d'America 179
CN - Cina 53
IT - Italia 46
IE - Irlanda 30
FR - Francia 14
SE - Svezia 14
BE - Belgio 11
GB - Regno Unito 8
IN - India 7
NL - Olanda 6
NG - Nigeria 5
CA - Canada 4
DE - Germania 4
IR - Iran 4
JP - Giappone 4
VN - Vietnam 4
PH - Filippine 3
PL - Polonia 3
TR - Turchia 3
ES - Italia 2
IL - Israele 2
KR - Corea 2
SG - Singapore 2
UG - Uganda 2
AM - Armenia 1
BR - Brasile 1
HK - Hong Kong 1
HU - Ungheria 1
ID - Indonesia 1
MK - Macedonia 1
MX - Messico 1
MY - Malesia 1
NO - Norvegia 1
RO - Romania 1
RU - Federazione Russa 1
TW - Taiwan 1
UA - Ucraina 1
Totale 425
Città #
Chandler 40
Dublin 30
Fairfield 12
Nyköping 11
Torino 9
Houston 7
Medford 7
Redwood City 7
Shanghai 7
Seattle 6
Ashburn 5
Beijing 5
Paris 5
Princeton 5
Turin 5
Abuja 4
Chengdu 4
Esneux 4
Genoa 4
Milan 4
New York 4
Pune 4
Calgary 3
Hangzhou 3
Jiaxing 3
Nanjing 3
Sigean 3
Wilmington 3
Bagnoli del Trigno 2
Bellingham 2
Brussels 2
Cambridge 2
Düsseldorf 2
Hebei 2
Hoevenen 2
Istanbul 2
Jerusalem 2
Klaaswaal 2
Madrid 2
Rome 2
San Diego 2
Singapore 2
Strijen 2
Vlaardingen 2
Woodbridge 2
Akron 1
Americana 1
Ankara 1
Ann Arbor 1
Arau 1
Ashiharacho 1
Bacoli 1
Bacoor 1
Bangalore 1
Boston 1
Chandigarh 1
Changsha 1
Cluj-napoca 1
Deposit 1
Duncan 1
El Fuerte 1
Fremont 1
Frosinone 1
Guiyang 1
Harbin 1
Hayward 1
Hefei 1
Homer 1
Homps 1
Honolulu 1
Hyderabad 1
Isfahan 1
Jacksonville 1
Kagoshima 1
Kelseyville 1
Lagos 1
London 1
Lyon 1
Macerata 1
Moncalieri 1
Nanchang 1
Nonette 1
Norwalk 1
Oslo 1
Padova 1
Pittsburgh 1
Plainville 1
Prilep 1
Riverton 1
Royal Leamington Spa 1
San Jose 1
Seoul 1
Seregno 1
Seriate 1
Southwark 1
Suzhou 1
Taipei 1
Taormina 1
Tempe 1
Tokyo 1
Totale 296
Nome #
The MITO CERV-2 trial: A randomized phase II study of cetuximab plus carboplatin and paclitaxel, in advanced or recurrent cervical cancer 233
Characteristics and outcome of BRCA mutated epithelial ovarian cancer patients in Italy: A retrospective multicenter study (MITO 21) 52
Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies 45
Conservative surgery in stage I adult type granulosa cells tumors of the ovary: Results from the MITO-9 study 33
The prognostic value of pain in castration-sensitive prostate cancer 24
Prescribing pattern of anticoagulants in patients with cancer associated thrombosis: Results of a survey among MITO group and AIOM society 17
Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study 12
Immune-inflammatory biomarkers as prognostic factors for immunotherapy in pretreated advanced urinary tract cancer patients: an analysis of the Italian SAUL cohort 11
Cabozantinib beyond progression improves survival in advanced renal cell carcinoma patients: the CABEYOND study (Meet-URO 21) 9
Single-Agent Trabectedin Versus Physician's Choice Chemotherapy in Patients With Recurrent Ovarian Cancer With BRCA-Mutated and/or BRCAness Phenotype: A Randomized Phase III Trial 3
Totale 439
Categoria #
all - tutte 1.683
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.683


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20209 0 0 0 0 2 0 0 1 1 0 1 4
2020/202174 1 3 5 4 5 9 3 2 6 20 9 7
2021/2022100 4 11 2 11 6 5 3 5 14 3 18 18
2022/2023152 8 7 2 9 17 32 12 23 13 5 12 12
2023/2024104 20 16 6 13 7 18 3 16 5 0 0 0
Totale 439